Sentence examples for more favourable cost from inspiring English sources

This is likely to produce a much more favourable cost per QALY.

Although the price per tablet of more recently developed drugs (ACEi, ARBs) is higher than that of older ones (diuretics and BBs), the newer drugs result in a more favourable cost to effect ratio when direct drug costs and indirect costs are also considered.

Nonetheless, recent evidence underlines the long-term oncological non-inferiority of percutaneous ablation methods compared to surgical resection, coupled with its unique properties of a completely incisionless procedure, lower rate of complications, better preservation of renal function and more favourable cost-effectiveness profile compared to partial nephrectomy.

The inclusion of pertussis related deaths would probably lead to a slightly more favourable cost-effectiveness as adolescent vaccination is estimated to slightly decrease the incidence in the most vulnerable group (i.e. young infants).

The EQ-5D tends to provide larger change scores and more favourable cost-effectiveness ratios than the SF-6D [ 77].

Our findings are in contrast to other studies where smoking-cessation among younger cohorts has more favourable cost-effectiveness than for older cohorts.

The choice of including the risk of developing CHD when suffering from diabetes would possibly lead to a more favourable cost-effectiveness ratio for asenapine.

These results show that the use of Spanish observational data not only increases the external validity of the results, but also yields a slightly more favourable cost-effectiveness outcome than the use of international clinical trial data.

A smaller increase in life expectancy of 1 year per decade saw an earlier age of death, fewer pathologies detected, less costs and a more favourable cost-effectiveness ratio.

At present the EQ-5D tends to provide a wider scoring range and better completion rates than the SF-6D [ 23] and tends to provide more favourable cost-effectiveness ratios [ 30].

As an example, lower prices for dabigatran in Europe compared with those in the USA were resulted in more favourable cost-effectiveness ratios despite smaller estimated gains in quality-adjusted survival [ 7].